Omega-3 fatty acids vs corn oil, major adverse cardiovascular events in patients at high risk

(JAMA Network) This randomized trial examines the effects on cardiovascular outcomes of a carboxylic acid formulation of EPA and DHA (omega-3 CA) with documented favorable effects on lipid and inflammatory markers in patients with atherogenic dyslipidemia and high cardiovascular risk.